{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:13:45Z","timestamp":1791328425635,"version":"4.3.1"},"reference-count":100,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"vor","delay-in-days":848,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"HHS NIH National Heart, Lung, and Blood Institute (NHLBI)","doi-asserted-by":"publisher","award":["K08HL130944"],"award-info":[{"award-number":["K08HL130944"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"HHS NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","doi-asserted-by":"publisher","award":["P30DK081943"],"award-info":[{"award-number":["P30DK081943"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"HHS NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","doi-asserted-by":"publisher","award":["P30DK089503"],"award-info":[{"award-number":["P30DK089503"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Renal Research Institute","award":["2015"],"award-info":[{"award-number":["2015"]}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1074\/jbc.ra117.000559","type":"journal-article","created":{"date-parts":[[2018,3,26]],"date-time":"2018-03-26T16:40:15Z","timestamp":1522082415000},"page":"7238-7249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Myeloperoxidase-derived oxidants damage artery wall proteins in an animal model of chronic kidney disease\u2013accelerated atherosclerosis"],"prefix":"10.1016","volume":"293","author":[{"given":"Lixia","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna V.","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeman","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin B.","family":"Atkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Frank C.","family":"Brosius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subramaniam","family":"Pennathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.RA117.000559_bib1","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/jbc.RA117.000559_bib2","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","article-title":"Clinical epidemiology of cardiovascular disease in chronic renal disease","volume":"32","author":"Foley","year":"1998","journal-title":"Am. J. Kidney Dis"},{"key":"10.1074\/jbc.RA117.000559_bib3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1523-1755.2000.00173.x","article-title":"Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients","volume":"58","author":"Cheung","year":"2000","journal-title":"Kidney Int"},{"key":"10.1074\/jbc.RA117.000559_bib4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.5414\/CNP57327","article-title":"Cardiovascular disease risk factors in chronic renal insufficiency","volume":"57","author":"Sarnak","year":"2002","journal-title":"Clin. Nephrol"},{"key":"10.1074\/jbc.RA117.000559_bib5","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1161\/01.HYP.0000102971.85504.7c","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention","volume":"42","author":"Sarnak","year":"2003","journal-title":"Hypertension"},{"key":"10.1074\/jbc.RA117.000559_bib6","series-title":"Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States","year":"2017"},{"key":"10.1074\/jbc.RA117.000559_bib7","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1056\/NEJMe048211","article-title":"Chronic kidney disease predicts cardiovascular disease","volume":"351","author":"Hostetter","year":"2004","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/jbc.RA117.000559_bib8","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2005111204","article-title":"Kidney function and risk of peripheral arterial disease: results from the Atherosclerosis Risk in Communities (ARIC) Study","volume":"18","author":"Wattanakit","year":"2007","journal-title":"J. Am. Soc. Nephrol"},{"key":"10.1074\/jbc.RA117.000559_bib9","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrneph.2010.143","article-title":"Atherosclerosis in CKD: differences from the general population","volume":"6","author":"Dr\u00fceke","year":"2010","journal-title":"Nat. Rev. Nephrol"},{"key":"10.1074\/jbc.RA117.000559_bib10","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1097\/HJH.0b013e3283495cd6","article-title":"Clinical significance of nonalbuminuric renal impairment in type 2 diabetes","volume":"29","author":"Penno","year":"2011","journal-title":"J. Hypertens"},{"key":"10.1074\/jbc.RA117.000559_bib11","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.arcmed.2015.05.009","article-title":"Residual cardiovascular risk in chronic kidney disease: role of high-density lipoprotein","volume":"46","author":"Kon","year":"2015","journal-title":"Arch. Med. Res"},{"key":"10.1074\/jbc.RA117.000559_bib12","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1093\/ndt\/gfg074","article-title":"Oxidative stress in end-stage renal disease: an emerging threat to patient outcome","volume":"18","author":"Locatelli","year":"2003","journal-title":"Nephrol. Dial. Transplant"},{"key":"10.1074\/jbc.RA117.000559_bib13","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000330327","article-title":"Increased calcification and protein nitration in arteries of chronic kidney disease patients","volume":"32","author":"Guilgen","year":"2011","journal-title":"Blood Purif"},{"key":"10.1074\/jbc.RA117.000559_bib14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.semnephrol.2004.06.026","article-title":"Oxidative stress in uremia: Nature, mechanisms, and potential consequences","volume":"24","author":"Vaziri","year":"2004","journal-title":"Semin. Nephrol"},{"key":"10.1074\/jbc.RA117.000559_bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00041552-200401000-00013","article-title":"Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension","volume":"13","author":"Vaziri","year":"2004","journal-title":"Curr. Opin. Nephrol. Hypertens"},{"key":"10.1074\/jbc.RA117.000559_bib16","doi-asserted-by":"crossref","first-page":"A3","DOI":"10.1016\/S1520-765X(03)90057-5","article-title":"Oxidative stress, the renin-angiotensin system, and atherosclerosis","volume":"5","author":"Landmesser","year":"2003","journal-title":"Eur. Heart J. Suppl"},{"key":"10.1074\/jbc.RA117.000559_bib17","doi-asserted-by":"crossref","first-page":"480","DOI":"10.7326\/0003-4819-93-3-480","article-title":"Oxygen metabolism and the toxic properties of phagocytes","volume":"93","author":"Klebanoff","year":"1980","journal-title":"Ann. Intern. Med"},{"key":"10.1074\/jbc.RA117.000559_bib18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2013an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/jbc.RA117.000559_bib19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0092-8674(92)90346-E","article-title":"Koch's postulates for cholesterol","volume":"71","author":"Brown","year":"1992","journal-title":"Cell"},{"key":"10.1074\/jbc.RA117.000559_bib20","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1073\/pnas.76.1.333","article-title":"Binding site on macrophages that mediates uptake and degradation of acetylated low-density lipoprotein, producing massive cholesterol deposition","volume":"76","author":"Goldstein","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA117.000559_bib21","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1172\/JCI115499","article-title":"Role of oxidized low-density lipoprotein in atherogenesis","volume":"88","author":"Witztum","year":"1991","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.RA117.000559_bib22","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/nm1102-1211","article-title":"Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime","volume":"8","author":"Steinberg","year":"2002","journal-title":"Nat. Med"},{"key":"10.1074\/jbc.RA117.000559_bib23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1126\/science.2455346","article-title":"Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits","volume":"241","author":"Haberland","year":"1988","journal-title":"Science"},{"key":"10.1074\/jbc.RA117.000559_bib24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/01.ATV.14.1.32","article-title":"Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL","volume":"14","author":"Yl\u00e4-Herttuala","year":"1994","journal-title":"Arterioscler. Thromb"},{"key":"10.1074\/jbc.RA117.000559_bib25","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1172\/JCI114271","article-title":"Evidence for the presence of oxidatively modified low-density lipoprotein in atherosclerotic lesions of rabbit and man","volume":"84","author":"Yl\u00e4-Herttuala","year":"1989","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.RA117.000559_bib26","first-page":"263","article-title":"The role of myeloperoxidase in the microbicidal activity of polymorphonuclear leukocytes","author":"Klebanoff","year":"1978","journal-title":"Ciba Found. Symp"},{"key":"10.1074\/jbc.RA117.000559_bib27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/B978-0-12-385928-0.00005-5","article-title":"Quantitative analysis of amino acid oxidation markers by tandem mass spectrometry","volume":"491","author":"Vivekanandan-Giri","year":"2011","journal-title":"Methods Enzymol"},{"key":"10.1074\/jbc.RA117.000559_bib28","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1172\/JCI119379","article-title":"3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low-density lipoprotein isolated from human atherosclerotic intima","volume":"99","author":"Hazen","year":"1997","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.RA117.000559_bib29","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/34923","article-title":"Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils","volume":"391","author":"Eiserich","year":"1998","journal-title":"Nature"},{"key":"10.1074\/jbc.RA117.000559_bib30","doi-asserted-by":"crossref","first-page":"32030","DOI":"10.1074\/jbc.273.48.32030","article-title":"Electron paramagnetic resonance detection of free tyrosyl radical generated by myeloperoxidase, lactoperoxidase, and horseradish peroxidase","volume":"273","author":"McCormick","year":"1998","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA117.000559_bib31","doi-asserted-by":"crossref","first-page":"17415","DOI":"10.1074\/jbc.M112400200","article-title":"A tale of two controversies: defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species","volume":"277","author":"Brennan","year":"2002","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA117.000559_bib32","doi-asserted-by":"crossref","first-page":"37524","DOI":"10.1074\/jbc.275.48.37524","article-title":"Nitric oxide is a physiological substrate for mammalian peroxidases","volume":"275","author":"Abu-Soud","year":"2000","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA117.000559_bib33","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1172\/JCI117342","article-title":"Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions","volume":"94","author":"Daugherty","year":"1994","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.RA117.000559_bib34","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1172\/JCI118576","article-title":"Presence of hypochlorite-modified proteins in human atherosclerotic lesions","volume":"97","author":"Hazell","year":"1996","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.RA117.000559_bib35","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1074\/jbc.272.3.1433","article-title":"Reactive nitrogen intermediates promote low-density lipoprotein oxidation in human atherosclerotic intima","volume":"272","author":"Leeuwenburgh","year":"1997","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA117.000559_bib36","doi-asserted-by":"crossref","first-page":"9957","DOI":"10.1074\/jbc.275.14.9957","article-title":"p-Hydroxyphenylacetaldehyde, an aldehyde generated by myeloperoxidase, modifies phospholipid amino groups of low-density lipoprotein in human atherosclerotic intima","volume":"275","author":"Heller","year":"2000","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA117.000559_bib37","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa035003","article-title":"Prognostic value of myeloperoxidase in patients with chest pain","volume":"349","author":"Brennan","year":"2003","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/jbc.RA117.000559_bib38","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1172\/JCI11194","article-title":"A hydroxyl radical-like species oxidizes cynomolgus monkey artery wall proteins in early diabetic vascular disease","volume":"107","author":"Pennathur","year":"2001","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.RA117.000559_bib39","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0891-5849(02)00993-0","article-title":"Spatial mapping of pulmonary and vascular nitrotyrosine reveals the pivotal role of myeloperoxidase as a catalyst for tyrosine nitration in inflammatory diseases","volume":"33","author":"Baldus","year":"2002","journal-title":"Free Radic. Biol. Med"},{"key":"10.1074\/jbc.RA117.000559_bib40","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2143\/AC.63.2.2029520","article-title":"Plasma myeloperoxidase is related to the severity of coronary artery disease","volume":"63","author":"D\u00fczg\u00fcn\u00e7inar","year":"2008","journal-title":"Acta Cardiol"},{"key":"10.1074\/jbc.RA117.000559_bib41","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1001\/jama.289.13.1675","article-title":"Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy","volume":"289","author":"Shishehbor","year":"2003","journal-title":"JAMA"},{"key":"10.1074\/jbc.RA117.000559_bib42","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1161\/01.CIR.0000080895.05158.8B","article-title":"Statins promote potent systemic antioxidant effects through specific inflammatory pathways","volume":"108","author":"Shishehbor","year":"2003","journal-title":"Circulation"},{"key":"10.1074\/jbc.RA117.000559_bib43","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11883-004-0038-1","article-title":"Inflammatory and oxidative markers in atherosclerosis: relationship to outcome","volume":"6","author":"Shishehbor","year":"2004","journal-title":"Curr. Atheroscler. Rep"},{"key":"10.1074\/jbc.RA117.000559_bib44","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1136\/annrheumdis-2012-202033","article-title":"High density lipoprotein is targeted for oxidation by myeloperoxidase in rheumatoid arthritis","volume":"72","author":"Vivekanandan-Giri","year":"2013","journal-title":"Ann. Rheum. Dis"},{"key":"10.1074\/jbc.RA117.000559_bib45","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1002\/art.38703","article-title":"Neutrophil extracellular trap-derived enzymes oxidize high-density lipoprotein: an additional proatherogenic mechanism in systemic lupus erythematosus","volume":"66","author":"Smith","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1074\/jbc.RA117.000559_bib46","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/nm1637","article-title":"Protein carbamylation links inflammation, smoking, uremia and atherogenesis","volume":"13","author":"Wang","year":"2007","journal-title":"Nat. Med"},{"key":"10.1074\/jbc.RA117.000559_bib47","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1373\/clinchem.2011.163188","article-title":"Carbamylation-derived products: bioactive compounds and potential biomarkers in chronic renal failure and atherosclerosis","volume":"57","author":"Jaisson","year":"2011","journal-title":"Clin. Chem"},{"key":"10.1074\/jbc.RA117.000559_bib48","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.cardfail.2013.02.001","article-title":"Protein carbamylation in chronic systolic heart failure: relationship with renal impairment and adverse long-term outcomes","volume":"19","author":"Tang","year":"2013","journal-title":"J. Card. Fail"},{"key":"10.1074\/jbc.RA117.000559_bib49","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1681\/ASN.2012030254","article-title":"Protein carbamylation predicts mortality in ESRD","volume":"24","author":"Koeth","year":"2013","journal-title":"J. Am. Soc. Nephrol"},{"key":"10.1074\/jbc.RA117.000559_bib50","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1053\/j.ajkd.2010.05.008","article-title":"Prognostic value of plasma myeloperoxidase in ESRD patients","volume":"56","author":"Wang","year":"2010","journal-title":"Am. J. Kidney Dis"},{"key":"10.1074\/jbc.RA117.000559_bib51","doi-asserted-by":"crossref","first-page":"1069743","DOI":"10.1155\/2016\/1069743","article-title":"Role of myeloperoxidase in patients with chronic kidney disease","volume":"2016","author":"Kisic","year":"2016","journal-title":"Oxid. Med. Cell. Longev"},{"key":"10.1074\/jbc.RA117.000559_bib52","doi-asserted-by":"crossref","first-page":"A438","DOI":"10.1096\/fasebj.21.5.A438-d","article-title":"Hemodialysis mediated upregulation of myeloperoxidase in end-stage renal disease: pathophysiologic implications","volume":"21","author":"Bansal","year":"2007","journal-title":"FASEB J"},{"key":"10.1074\/jbc.RA117.000559_bib53","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s12291-010-0075-1","article-title":"Myeloperoxidase in chronic kidney disease","volume":"26","author":"Madhusudhana Rao","year":"2011","journal-title":"Indian J. Clin. Biochem"},{"key":"10.1074\/jbc.RA117.000559_bib54","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000477766","article-title":"Myeloperoxidase levels and its product 3-chlorotyrosine predict chronic kidney disease severity and associated coronary artery disease","volume":"46","author":"Afshinnia","year":"2017","journal-title":"Am. J. Nephrol"},{"key":"10.1074\/jbc.RA117.000559_bib55","doi-asserted-by":"crossref","first-page":"34621","DOI":"10.1074\/jbc.274.49.34621","article-title":"Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and o,o\u2032-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson's disease","volume":"274","author":"Pennathur","year":"1999","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA117.000559_bib56","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1172\/JCI8797","article-title":"Increased atherosclerosis in myeloperoxidase-deficient mice","volume":"107","author":"Brennan","year":"2001","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.RA117.000559_bib57","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1161\/CIRCULATIONAHA.104.516278","article-title":"Expression of human myeloperoxidase by macrophages promotes atherosclerosis in mice","volume":"111","author":"McMillen","year":"2005","journal-title":"Circulation"},{"issue":"Suppl. 14","key":"10.1074\/jbc.RA117.000559_bib58","article-title":"Metabolomic profiling of arginine metabolome links altered methylation to chronic kidney disease\u2013accelerated atherosclerosis","author":"Mathew","year":"2015","journal-title":"J. Proteomics Bioinform"},{"key":"10.1074\/jbc.RA117.000559_bib59","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1046\/j.1523-1755.2001.060002472.x","article-title":"Pathophysiological mechanisms of vascular calcification in end-stage renal disease","volume":"60","author":"Davies","year":"2001","journal-title":"Kidney Int"},{"key":"10.1074\/jbc.RA117.000559_bib60","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1097\/01.ASN.0000068404.57780.DD","article-title":"BMP-7 is an efficacious treatment of vascular calcification in a murine model of atherosclerosis and chronic renal failure","volume":"14","author":"Davies","year":"2003","journal-title":"J. Am. Soc. Nephrol"},{"key":"10.1074\/jbc.RA117.000559_bib61","doi-asserted-by":"crossref","first-page":"e0168396","DOI":"10.1371\/journal.pone.0168396","article-title":"Liraglutide reduces both atherosclerosis and kidney inflammation in moderately uremic LDLr\u2212\/\u2212 mice","volume":"11","author":"Bisgaard","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1074\/jbc.RA117.000559_bib62","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1164\/rccm.201505-0992OC","article-title":"Oxidative modifications of protein tyrosyl residues are increased in plasma of human subjects with interstitial lung disease","volume":"193","author":"Pennathur","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"10.1074\/jbc.RA117.000559_bib63","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1074\/jbc.272.6.3520","article-title":"Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low-density lipoprotein isolated from human atherosclerotic plaques","volume":"272","author":"Leeuwenburgh","year":"1997","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA117.000559_bib64","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1172\/JCI200421109","article-title":"Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease","volume":"114","author":"Zheng","year":"2004","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.RA117.000559_bib65","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1093\/ndt\/gfl398","article-title":"Oxidative stress and atherosclerosis in early chronic kidney disease","volume":"21","author":"Zalba","year":"2006","journal-title":"Nephrol. Dial. Transplant"},{"key":"10.1074\/jbc.RA117.000559_bib66","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12944-016-0191-x","article-title":"Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study","volume":"15","author":"Gluba-Brz\u00f3zka","year":"2016","journal-title":"Lipids Health Dis"},{"key":"10.1074\/jbc.RA117.000559_bib67","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrneph.2010.157","article-title":"Atherosclerosis in chronic kidney disease: the role of macrophages","volume":"7","author":"Kon","year":"2011","journal-title":"Nat. Rev. Nephrol"},{"key":"10.1074\/jbc.RA117.000559_bib68","first-page":"401","article-title":"Molecular analysis of the human myeloperoxidase promoter region","volume":"16","author":"Chumakov","year":"2000","journal-title":"Int. J. Oncol"},{"key":"10.1074\/jbc.RA117.000559_bib69","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.amjmed.2003.10.025","article-title":"Myeloperoxidase polymorphism related to cardiovascular events in coronary artery disease","volume":"116","author":"Asselbergs","year":"2004","journal-title":"Am. J. Med"},{"key":"10.1074\/jbc.RA117.000559_bib70","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1067\/mhj.2001.116769","article-title":"A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians","volume":"142","author":"Nikpoor","year":"2001","journal-title":"Am. Heart J"},{"key":"10.1074\/jbc.RA117.000559_bib71","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000100419","article-title":"Associations between the CYBA 242C\/T and the MPO \u2212463G\/A polymorphisms, oxidative stress and cardiovascular disease in chronic kidney disease patients","volume":"25","author":"Grahl","year":"2007","journal-title":"Blood Purif"},{"key":"10.1074\/jbc.RA117.000559_bib72","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1046\/j.1523-1755.63.s84.32.x","article-title":"A functional variant of the myeloperoxidase gene is associated with cardiovascular disease in end-stage renal disease patients","volume":"2003","author":"Pecoits-Filho","year":"2003","journal-title":"Kidney Int. Suppl"},{"key":"10.1074\/jbc.RA117.000559_bib73","doi-asserted-by":"crossref","first-page":"14412","DOI":"10.1074\/jbc.271.24.14412","article-title":"An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element","volume":"271","author":"Piedrafita","year":"1996","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA117.000559_bib74","doi-asserted-by":"crossref","first-page":"8300","DOI":"10.1074\/jbc.M311625200","article-title":"Peroxisome proliferator-activated receptor gamma ligands regulate myeloperoxidase expression in macrophages by an estrogen-dependent mechanism involving the \u2212463GA promoter polymorphism","volume":"279","author":"Kumar","year":"2004","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA117.000559_bib75","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.bbrc.2005.03.204","article-title":"Statins downregulate myeloperoxidase gene expression in macrophages","volume":"331","author":"Kumar","year":"2005","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1074\/jbc.RA117.000559_bib76","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.bbrc.2006.08.119","article-title":"The human myeloperoxidase gene is regulated by LXR and PPAR\u03b1 ligands","volume":"349","author":"Reynolds","year":"2006","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1074\/jbc.RA117.000559_bib77","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1194\/jlr.M600005-JLR200","article-title":"Transgenic mice express human MPO \u2212463G\/A alleles at atherosclerotic lesions, developing hyperlipidemia and obesity in \u2212463G males","volume":"47","author":"Castellani","year":"2006","journal-title":"J. Lipid Res"},{"key":"10.1074\/jbc.RA117.000559_bib78","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1056\/NEJM200401293500519","article-title":"Prognostic value of myeloperoxidase in patients with chest pain","volume":"350","author":"Cayley","year":"2004","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/jbc.RA117.000559_bib79","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1291\/hypres.30.1193","article-title":"Functional polymorphism of the myeloperoxidase gene in hypertensive nephrosclerosis dialysis patients","volume":"30","author":"Doi","year":"2007","journal-title":"Hypertens. Res"},{"key":"10.1074\/jbc.RA117.000559_bib80","first-page":"2028","article-title":"Association of the G-463A myeloperoxidase gene polymorphism with renal disease in African Americans with systemic lupus erythematosus","volume":"34","author":"Bouali","year":"2007","journal-title":"J. Rheumatol"},{"key":"10.1074\/jbc.RA117.000559_bib81","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1097\/01.ASN.0000088024.72216.2E","article-title":"Chronic renal failure accelerates atherogenesis in apolipoprotein E-deficient mice","volume":"14","author":"Bro","year":"2003","journal-title":"J. Am. Soc. Nephrol"},{"key":"10.1074\/jbc.RA117.000559_bib82","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.cca.2010.06.019","article-title":"Mechanism of endothelial dysfunction in chronic kidney disease","volume":"411","author":"Malyszko","year":"2010","journal-title":"Clin. Chim. Acta"},{"key":"10.1074\/jbc.RA117.000559_bib83","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.thromres.2009.11.008","article-title":"The effect of the long term aspirin administration on the progress of atherosclerosis in apoE\u2212\/\u2212 LDLR\u2212\/\u2212 double knockout mouse","volume":"125","author":"Yamamoto","year":"2010","journal-title":"Thromb. Res"},{"key":"10.1074\/jbc.RA117.000559_bib84","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.prostaglandins.2012.02.002","article-title":"Functional alterations in endothelial NO, PGI(2) and EDHF pathways in aorta in ApoE\/LDLR\u2212\/\u2212 mice","volume":"98","author":"Cs\u00e1nyi","year":"2012","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1074\/jbc.RA117.000559_bib85","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1159\/000088101","article-title":"Intact endothelium-dependent dilation and conducted responses in resistance vessels of hypercholesterolemic mice in vivo","volume":"42","author":"W\u00f6lfle","year":"2005","journal-title":"J. Vasc. Res"},{"key":"10.1074\/jbc.RA117.000559_bib86","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s00380-008-1066-5","article-title":"Effects of dietary sodium on reactive oxygen species formation and endothelial dysfunction in low-density lipoprotein receptor-deficient mice on high-fat diet","volume":"23","author":"Ketonen","year":"2008","journal-title":"Heart Vessels"},{"key":"10.1074\/jbc.RA117.000559_bib87","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/1476-511X-10-211","article-title":"Endothelial dysfunction in the apolipoprotein E-deficient mouse: insights into the influence of diet, gender and aging","volume":"10","author":"Meyrelles","year":"2011","journal-title":"Lipids Health Dis"},{"key":"10.1074\/jbc.RA117.000559_bib88","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jsbmb.2014.12.002","article-title":"Different vitamin D receptor agonists exhibit differential effects on endothelial function and aortic gene expression in 5\/6 nephrectomized rats","volume":"148","author":"Wu-Wong","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol"},{"key":"10.1074\/jbc.RA117.000559_bib89","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1159\/000362507","article-title":"Phosphate binding reduces aortic angiotensin-converting enzyme and enhances nitric oxide bioactivity in experimental renal insufficiency","volume":"39","author":"Er\u00e4ranta","year":"2014","journal-title":"Am. J. Nephrol"},{"key":"10.1074\/jbc.RA117.000559_bib90","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1161\/01.ATV.0000201060.47945.cb","article-title":"Uremia-specific effects in the arterial media during development of uremic atherosclerosis in apolipoprotein E-deficient mice","volume":"26","author":"Bro","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"10.1074\/jbc.RA117.000559_bib91","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1161\/ATVBAHA.107.139634","article-title":"Inhibition of the renin-angiotensin system abolishes the proatherogenic effect of uremia in apolipoprotein E-deficient mice","volume":"27","author":"Bro","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"10.1074\/jbc.RA117.000559_bib92","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.atherosclerosis.2008.01.015","article-title":"A neutralizing antibody against receptor for advanced glycation end products (RAGE) reduces atherosclerosis in uremic mice","volume":"201","author":"Bro","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1074\/jbc.RA117.000559_bib93","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1080\/00365510802037272","article-title":"Cardiac structure and function in a mouse model of uraemia without hypertension","volume":"68","author":"Bro","year":"2008","journal-title":"Scand. J. Clin. Lab. Invest"},{"key":"10.1074\/jbc.RA117.000559_bib94","first-page":"177","article-title":"Cardiovascular effects of uremia in apolipoprotein E-deficient mice","volume":"56","author":"Bro","year":"2009","journal-title":"Dan. Med. Bull"},{"key":"10.1074\/jbc.RA117.000559_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0009-8981(92)90348-T","article-title":"Generation of analytic plasma lipoprotein profiles using two prepacked Superose 6B columns","volume":"205","author":"Gerdes","year":"1992","journal-title":"Clin. Chim. Acta"},{"key":"10.1074\/jbc.RA117.000559_bib96","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1681\/ASN.2004060495","article-title":"Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice","volume":"16","author":"Massy","year":"2005","journal-title":"J. Am. Soc. Nephrol"},{"key":"10.1074\/jbc.RA117.000559_bib97","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1161\/CIRCULATIONAHA105.541854","article-title":"Sevelamer prevents uremia-enhanced atherosclerosis progression in apolipoprotein E-deficient mice","volume":"112","author":"Phan","year":"2005","journal-title":"Circulation"},{"key":"10.1074\/jbc.RA117.000559_bib98","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/ndt\/gfm699","article-title":"Effect of oral calcium carbonate on aortic calcification in apolipoprotein E-deficient (apoE\u2212\/\u2212) mice with chronic renal failure","volume":"23","author":"Phan","year":"2008","journal-title":"Nephrol. Dial. Transplant"},{"key":"10.1074\/jbc.RA117.000559_bib99","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1159\/000299794","article-title":"Vascular calcification in animal models of CKD: a review","volume":"31","author":"Shobeiri","year":"2010","journal-title":"Am. J. Nephrol"},{"key":"10.1074\/jbc.RA117.000559_bib100","doi-asserted-by":"crossref","first-page":"e12299","DOI":"10.14814\/phy2.12299","article-title":"Maintenance of GLUT4 expression in smooth muscle prevents hypertension-induced changes in vascular reactivity","volume":"3","author":"Atkins","year":"2015","journal-title":"Physiol. Rep"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820392085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820392085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.RA117.000559","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T08:31:26Z","timestamp":1639816286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820392085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":100,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0021925820392085"],"URL":"https:\/\/doi.org\/10.1074\/jbc.ra117.000559","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myeloperoxidase-derived oxidants damage artery wall proteins in an animal model of chronic kidney disease\u2013accelerated atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.RA117.000559","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by The American Society for Biochemistry and Molecular Biology, Inc.","name":"copyright","label":"Copyright"}]}}